Table of Contents United States Biopharmaceuticals Market Report 2018 1 Biopharmaceuticals Overview 1.1 Product Overview and Scope of Biopharmaceuticals 1.2 Classification of Biopharmaceuticals by Product Category 1.2.1 United States Biopharmaceuticals Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Biopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Monoclonal Antibodies 1.2.4 Interferon 1.2.5 Colony-Stimulating Factor 1.2.6 Erythropoietin 1.2.7 Growth Hormones 1.2.8 Insulin 1.2.9 Vaccines 1.2.10 Others 1.3 United States Biopharmaceuticals Market by Application/End Users 1.3.1 United States Biopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Hemophilia 1.3.5 Cardiovascular 1.3.6 Others 1.4 United States Biopharmaceuticals Market by Region 1.4.1 United States Biopharmaceuticals Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Biopharmaceuticals Status and Prospect (2013-2025) 1.4.3 Southwest Biopharmaceuticals Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Biopharmaceuticals Status and Prospect (2013-2025) 1.4.5 New England Biopharmaceuticals Status and Prospect (2013-2025) 1.4.6 The South Biopharmaceuticals Status and Prospect (2013-2025) 1.4.7 The Midwest Biopharmaceuticals Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Biopharmaceuticals (2013-2025) 1.5.1 United States Biopharmaceuticals Sales and Growth Rate (2013-2025) 1.5.2 United States Biopharmaceuticals Revenue and Growth Rate (2013-2025) 2 United States Biopharmaceuticals Market Competition by Players/Suppliers 2.1 United States Biopharmaceuticals Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Biopharmaceuticals Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Biopharmaceuticals Average Price by Players/Suppliers (2013-2018) 2.4 United States Biopharmaceuticals Market Competitive Situation and Trends 2.4.1 United States Biopharmaceuticals Market Concentration Rate 2.4.2 United States Biopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type 3 United States Biopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Biopharmaceuticals Sales and Market Share by Region (2013-2018) 3.2 United States Biopharmaceuticals Revenue and Market Share by Region (2013-2018) 3.3 United States Biopharmaceuticals Price by Region (2013-2018) 4 United States Biopharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Biopharmaceuticals Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Biopharmaceuticals Revenue and Market Share by Type (2013-2018) 4.3 United States Biopharmaceuticals Price by Type (2013-2018) 4.4 United States Biopharmaceuticals Sales Growth Rate by Type (2013-2018) 5 United States Biopharmaceuticals Sales (Volume) by Application (2013-2018) 5.1 United States Biopharmaceuticals Sales and Market Share by Application (2013-2018) 5.2 United States Biopharmaceuticals Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Biopharmaceuticals Players/Suppliers Profiles and Sales Data 6.1 Roche 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Biopharmaceuticals Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Roche Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Pfizer 6.2.2 Biopharmaceuticals Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Amgen 6.3.2 Biopharmaceuticals Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Johnson & Johnson 6.4.2 Biopharmaceuticals Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Eli Lilly 6.5.2 Biopharmaceuticals Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Eli Lilly Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Novartis 6.6.2 Biopharmaceuticals Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 AbbVie 6.7.2 Biopharmaceuticals Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 AbbVie Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Novo Nordisk 6.8.2 Biopharmaceuticals Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Sanofi-Aventis 6.9.2 Biopharmaceuticals Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Sanofi-Aventis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Merck 6.10.2 Biopharmaceuticals Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Merck Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 7 Biopharmaceuticals Manufacturing Cost Analysis 7.1 Biopharmaceuticals Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Biopharmaceuticals 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Biopharmaceuticals Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Biopharmaceuticals Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Biopharmaceuticals Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Biopharmaceuticals Sales Volume Forecast by Type (2018-2025) 11.3 United States Biopharmaceuticals Sales Volume Forecast by Application (2018-2025) 11.4 United States Biopharmaceuticals Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Biopharmaceuticals Figure United States Biopharmaceuticals Market Size (K MT) by Type (2013-2025) Figure United States Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017 Figure Monoclonal Antibodies Product Picture Figure Interferon Product Picture Figure Colony-Stimulating Factor Product Picture Figure Erythropoietin Product Picture Figure Growth Hormones Product Picture Figure Insulin Product Picture Figure Vaccines Product Picture Figure Others Product Picture Figure United States Biopharmaceuticals Market Size (K MT) by Application (2013-2025) Figure United States Sales Market Share of Biopharmaceuticals by Application in 2017 Figure Tumor Examples Table Key Downstream Customer in Tumor Figure Diabetes Examples Table Key Downstream Customer in Diabetes Figure Hemophilia Examples Table Key Downstream Customer in Hemophilia Figure Cardiovascular Examples Table Key Downstream Customer in Cardiovascular Figure Others Examples Table Key Downstream Customer in Others Figure United States Biopharmaceuticals Market Size (Million USD) by Region (2013-2025) Figure The West Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Biopharmaceuticals Sales (K MT) and Growth Rate (2013-2025) Figure United States Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Biopharmaceuticals Market Major Players Product Sales Volume (K MT) (2013-2018) Table United States Biopharmaceuticals Sales (K MT) of Key Players/Suppliers (2013-2018) Table United States Biopharmaceuticals Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Biopharmaceuticals Sales Share by Players/Suppliers Figure 2017 United States Biopharmaceuticals Sales Share by Players/Suppliers Figure United States Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Biopharmaceuticals Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Biopharmaceuticals Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Biopharmaceuticals Revenue Share by Players/Suppliers Figure 2017 United States Biopharmaceuticals Revenue Share by Players/Suppliers Table United States Market Biopharmaceuticals Average Price (USD/MT) of Key Players/Suppliers (2013-2018) Figure United States Market Biopharmaceuticals Average Price (USD/MT) of Key Players/Suppliers in 2017 Figure United States Biopharmaceuticals Market Share of Top 3 Players/Suppliers Figure United States Biopharmaceuticals Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Biopharmaceuticals Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Biopharmaceuticals Product Category Table United States Biopharmaceuticals Sales (K MT) by Region (2013-2018) Table United States Biopharmaceuticals Sales Share by Region (2013-2018) Figure United States Biopharmaceuticals Sales Share by Region (2013-2018) Figure United States Biopharmaceuticals Sales Market Share by Region in 2017 Table United States Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Biopharmaceuticals Revenue Share by Region (2013-2018) Figure United States Biopharmaceuticals Revenue Market Share by Region (2013-2018) Figure United States Biopharmaceuticals Revenue Market Share by Region in 2017 Table United States Biopharmaceuticals Price (USD/MT) by Region (2013-2018) Table United States Biopharmaceuticals Sales (K MT) by Type (2013-2018) Table United States Biopharmaceuticals Sales Share by Type (2013-2018) Figure United States Biopharmaceuticals Sales Share by Type (2013-2018) Figure United States Biopharmaceuticals Sales Market Share by Type in 2017 Table United States Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Biopharmaceuticals Revenue Share by Type (2013-2018) Figure Revenue Market Share of Biopharmaceuticals by Type (2013-2018) Figure Revenue Market Share of Biopharmaceuticals by Type in 2017 Table United States Biopharmaceuticals Price (USD/MT) by Types (2013-2018) Figure United States Biopharmaceuticals Sales Growth Rate by Type (2013-2018) Table United States Biopharmaceuticals Sales (K MT) by Application (2013-2018) Table United States Biopharmaceuticals Sales Market Share by Application (2013-2018) Figure United States Biopharmaceuticals Sales Market Share by Application (2013-2018) Figure United States Biopharmaceuticals Sales Market Share by Application in 2017 Table United States Biopharmaceuticals Sales Growth Rate by Application (2013-2018) Figure United States Biopharmaceuticals Sales Growth Rate by Application (2013-2018) Table Roche Basic Information List Table Roche Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Roche Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Roche Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Roche Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Pfizer Basic Information List Table Pfizer Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Pfizer Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Pfizer Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Pfizer Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Amgen Basic Information List Table Amgen Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Amgen Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Amgen Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Amgen Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Johnson & Johnson Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Johnson & Johnson Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Johnson & Johnson Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Eli Lilly Basic Information List Table Eli Lilly Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Eli Lilly Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Eli Lilly Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Eli Lilly Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Novartis Basic Information List Table Novartis Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Novartis Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Novartis Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Novartis Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table AbbVie Basic Information List Table AbbVie Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure AbbVie Biopharmaceuticals Sales Growth Rate (2013-2018) Figure AbbVie Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure AbbVie Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Novo Nordisk Basic Information List Table Novo Nordisk Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Novo Nordisk Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Novo Nordisk Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Novo Nordisk Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Sanofi-Aventis Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Sanofi-Aventis Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Sanofi-Aventis Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Merck Basic Information List Table Merck Biopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Merck Biopharmaceuticals Sales Growth Rate (2013-2018) Figure Merck Biopharmaceuticals Sales Market Share in United States (2013-2018) Figure Merck Biopharmaceuticals Revenue Market Share in United States (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Biopharmaceuticals Figure Manufacturing Process Analysis of Biopharmaceuticals Figure Biopharmaceuticals Industrial Chain Analysis Table Raw Materials Sources of Biopharmaceuticals Major Players/Suppliers in 2017 Table Major Buyers of Biopharmaceuticals Table Distributors/Traders List Figure United States Biopharmaceuticals Sales Volume (K MT) and Growth Rate Forecast (2018-2025) Figure United States Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Biopharmaceuticals Price (USD/MT) Trend Forecast (2018-2025) Table United States Biopharmaceuticals Sales Volume (K MT) Forecast by Type (2018-2025) Figure United States Biopharmaceuticals Sales Volume (K MT) Forecast by Type (2018-2025) Figure United States Biopharmaceuticals Sales Volume (K MT) Forecast by Type in 2025 Table United States Biopharmaceuticals Sales Volume (K MT) Forecast by Application (2018-2025) Figure United States Biopharmaceuticals Sales Volume (K MT) Forecast by Application (2018-2025) Figure United States Biopharmaceuticals Sales Volume (K MT) Forecast by Application in 2025 Table United States Biopharmaceuticals Sales Volume (K MT) Forecast by Region (2018-2025) Table United States Biopharmaceuticals Sales Volume Share Forecast by Region (2018-2025) Figure United States Biopharmaceuticals Sales Volume Share Forecast by Region (2018-2025) Figure United States Biopharmaceuticals Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources